Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02407496 · ClinicalTrials.gov registry record
Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)
A clinical trial, sponsored by Think Now Incorporated.
- Completed
- Registry status
- 80
- Enrollment target
NCT02407496: Completed study, sponsored by Think Now Incorporated.
NCT02407496 is a clinical trial that has completed, run by Think Now Incorporated. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02407496 has completed, sponsored by Think Now Incorporated.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is develop a new assessment tool for Attention Deficit-Hyperactivity Disorder (ADHD) and to then test its validity (i.e. ability to discriminate between individuals with ADHD and healthy controls).
Primary Outcome
The NAT EEG test simultaneously generates 2 EEG values and 1 behavioral value that are used together as an assessment metric for ADHD. This is a one-time measure to assess its magnitude in ADHD vs Controls.
Interventions
- OTHER Behavioral assessment and NAT EEG tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-09 |
What the finished NCT02407496 record still lists
NCT02407496 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Behavioral assessment and NAT EEG tests is the first listed.
NCT02407496 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02407496 about?
NCT02407496 is a clinical study titled "Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)". The purpose of this study is develop a new assessment tool for Attention Deficit-Hyperactivity Disorder (ADHD) and to then test its validity (i.e. ability to discriminate between individuals with ADHD and healthy controls).
What is the current status of trial NCT02407496?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2014-06. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02407496?
The interventions under investigation include: Behavioral assessment and NAT EEG tests (OTHER).
Who is sponsoring clinical trial NCT02407496?
This trial is sponsored by Think Now Incorporated, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia